Insurance Australia Group's cash earnings collapse in half

Is Insurance Australia Group Ltd (ASX:IAG) a buy for dividend seekers?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

This morning Insurance Australia Group Ltd (ASX: IAG) reported its half-year results for the period ending December 31 2018. Below is a summary of the results with comparisons to the prior corresponding half.

  • Net profit after tax of $500 million, down 9.3%
  • Cash earnings of $319 million, down 49.4%
  • Interim dividend of 12 cents, down from 14 cents
  • Gross written premiums of $5,881 million, up from $5,649 million
  • Insurance profit $496 million, down 33.4%
  • Underlying insurance margin of 16.2%, up 0.70% on adjusted basis
  • Cash return on equity 9.8%, down 9.3%

This is a mixed set of results from the Warren Buffett-backed general insurance group behind the Nomura, CGU, Swann Insurance, NZI, and AMI insurance brands among others.

On the plus side gross written premiums (GWP) for the period have grown a decent 4.1% and its adjusted insurance margin is also 70 basis points higher to 16.2%, but on the downside this has not translated to profit or dividend growth.

The group also maintained guidance for GWP growth of 2%-4% over FY 2019 on a margin of 16%-18%.

The insurance margin is total GWP less reinsurance costs, less claims, commission and underwriting expenses, plus investment income to produce an 'insurance profit' as a percentage of GWP.

In effect this is equivalent to an operating profit and IAG blamed the lower insurance profit on a higher perils outcome in excess of allowance versus the comparable period, a lower prior period reserves release, and a negative swing of $70 million due to widening credit spreads, among other factors.

IAG continues to offer dividend seekers a good yield (4.3% on a trailing basis and higher when including one-off special dividends) and reasonable valuation, but it's only likely to interest conservatively minded dividend investors.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of Insurance Australia Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy'.
Cheap Shares

3 quality ASX shares to buy and hold until 2036

These aren’t struggling stocks and brokers remain highly bullish.

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Share Market News

5 things to watch on the ASX 200 on Thursday

It looks set to be a tough session for Aussie investors today.

Read more »

Three young people in business attire sit around a desk and discuss.
Opinions

Top 3 ASX 200 shares I'd buy today with $12,000

These are the shares I'd be buying right now.

Read more »

A young boy reaches up to touch the raindrops on his umbrella, as the sun comes out in the sky behind him.
Share Market News

Why these ASX shares could be buys in today's volatile market

This solid trio could help investors earn income and weather uncertainty.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »